Thomas Chung

Thomas Chung has a strong background in finance and corporate development. Thomas currently holds the position of Director, Strategic Finance & Corporate Development at Senti Biosciences, starting in September 2022. Prior to this, they worked in an investment fund/quantitative trading program as an Investor/Developer from 2018 to 2022. From 2011 to 2018, Thomas served as Vice President at Health Evolution Partners. Thomas also gained experience as an Associate at Crescent Capital Group LP from 2009 to 2011 and as an Analyst at UBS Investment Bank from 2007 to 2009. Thomas began their finance career as a Summer Analyst at Core Fund Management, LP in 2006.

From 2003 to 2007, Thomas Chung attended Stanford University where they earned a B.A. and B.S. degree. Thomas studied Economics and Biomedical Computations during their time at the university.